|
|
|
|
|
|
|
|
|
|
|
公司简介
——————
郑州人福博赛生物技术有限责任公司，人福医药集团（A股 SH600079）控股子公司，成立于1988年，前身为郑州博赛生物技术研究所。被河南省科技厅认定为高新技术企业，河南省抗体工程研究中心，郑州市抗体工程技术研究中心，中国河南留学生人员创业园优秀企业，与中国科学院上海生物化学与细胞生物学研究所合作建立体外诊断试剂转化基地。公司产品现已覆盖免疫（胶体金、酶免、化学发光等）、生化、微生物、分子生物学、单（多）克隆抗体、重组抗原等领域。
Zhengzhou Humanwell BIOCELL Biotech Co,. Ltd, founded in 1988 as one of the earlist IVD research instituten in China, is currently a fast growing, smallcap IVD product company with global largecap ambition. It is one of the top life science companies in China, with publicly listed company HUMANWELL as its largest shareholder. BIOCELL is specialized in development, production, distribution and technical support of IVD reagents, raw materials, and medical instrument. It has deep technical resources and IVD development capability. Over 115 IVD production lines have been certificated by the National Food and Drug Administration (CFDA) according to GMP standards.
我们的服务
——————
成立于1988，专注体外诊断三十年
|
|
|
|